Please login to the form below
digital therapy
This page shows the latest digital therapy news and features for those working in and with pharma, biotech and healthcare.
bluebird bio maintains its focus on gene therapy opportunities during structural changes
bluebird bio expects to maintain targeted research efforts focused on vivo lentiviral vector (LVV) gene therapy and will, therefore, deprioritise direct investments in reduced toxicity conditioning and cryopreserved apheresis. ... Digital inspiration for
Latest news
-
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Its Prescription Digital Therapeutics (PDTs) are app-based programmes which use cognitive behavioural therapy (CBT) to help patients with their conditions. ... However most patients do not receive or have access to the therapy – something which an
-
FDA chief Scott Gottlieb to step down
Despite taking on pharma market abuses, Gottlieb’s championing of faster approvals, closer working with the industry and new dedicated pathways for digital innovation and cell and gene therapy won the
-
Novartis aims for 10 blockbuster launches by 2020
Narasimhan is pushing the company towards a tighter focus on the most innovative medicines and leadership in digital innovation. ... Novartis CEO Vas Narasimhan. "Together with delivering strong accretive growth, we also advanced our strategic priorities
-
Digital tech from Autolus and Oxford BioMedica to speed advanced therapies
UK funds efforts to make country a leader in cell and gene therapy. ... The London-based company is developing its own next-generation CAR-T treatments, and has been supported by the government-funded Cell and Gene Therapy Catapult.
-
Bluebird’s first gene therapy gets European fast track
Today’s announcement from the EMA means an approval for the gene therapy could come in 2019. ... Bluebird Bio: on the cusp of a gene therapy revolution (PME July/August Digital Edition).
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
These three gene therapy approaches have been used in various guises for some time, while the fourth approach, gene editing, is the newest kid on the block. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations
-
A relentless commitment to neuroscience
For example, the ability to harness digital health technology, big data and cutting-edge computing is helping to unlock new possibilities including further understanding of the mechanisms of disease, novel targets, ... digital biomarkers, the impact of
-
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential. ... The promise is appealing, with a McKinsey report forecasting that healthcare innovations – from digital tools to gene and
-
CAR-T cell therapy in oncology
Time required to produce individualised therapy, necessitating patients wait for weeks before treatment. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.
-
Rare Diseases Day
On first glance, it appears that the level of personalised human support needed for each complex case is not suited to the kind of digital therapy management and patient support services ... It’s a complex and frustrating process. Could there be a role
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
However, the real value lies when digital therapeutics are combined with a medicinal asset. ... Digital therapeutics market growth . Key therapy areas and applications. Detailed benefits for stakeholders and advice on overcoming adoption hurdles.
-
Extraordinary lives: advancing change in rare diseases (Part 2)
The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies ... About Lucid Group. Founded in 2007, Lucid Group is a
-
Extraordinary lives: advancing change in rare diseases (Part 2)
The panel also give captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies ... About Lucid Group. Founded in 2007, Lucid Group is a
-
Advancing Our Profession: Driving Leadership and Best Practices in Medical Communications – Key themes and highlights from the 2022 European Meeting of ISMPP
in digital health are making it easier to collect data from patients via mobile phone applications. ... of the medical publications landscape in digital health during the 2010–2020 period, authored by Weedon et al.
-
Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
Lydia Zeller, CEO at Kiio, explores digital therapeutics, healthcare innovation, and Kiio’s innovative and personalized solutions for musculoskeletal (MSK) pain. ... She also shares her key leadership lessons and predictions for the future of digital
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
